Antitumor agent-100 (compound A6) is an orally active apoptosis inducer and a molecular glue targeting PDE3A-SLFN12 (IC50: 0.3 μM), exhibiting antitumor activity by binding to the PDE3A enzyme pocket to recruit and stabilize SLFN12, thereby inhibiting protein translation and inducing apoptosis.